ArticleJournal for immunotherapy of cancer2024

Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer.

Marta Molina-Alejandre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.